SOLVAY SA (SOLB.BR) 101.175 +3.31 (+3.39%)
101.175 +3.31 (+3.39%)
BE0003470755 - Common Stock
Fundamental Rating
We assign a fundamental rating of 5 out of 10 to SOLB. SOLB was compared to 31 industry peers in the Chemicals industry. SOLB has a bad profitability rating. Also its financial health evaluation is rather negative. A decent growth rate in combination with a cheap valuation! Better keep an eye on SOLB.
Profitability
Profitability Rating
SOLB's Profit Margin of 11.51% is amongst the best of the industry. SOLB does better than the industry average Profit Margin of 9.22%.
The Piotroski-F score of SOLB is 5.00. This is a neutral score and indicates average health and profitability for SOLB.
SOLB has a Return On Assets of 7.35%. This is below the industry average of 8.84%.
SOLB's Return On Equity of 15.78% is worse than the rest of the industry. The industry average Return On Equity is 17.73%.
VS Industry
ROA (7.35%) VS Industry: 40% outperformed.
2.22
19.77
ROE (15.78%) VS Industry: 40% outperformed.
4.93
36.57
Profit Margin (11.51%) VS Industry: 61% outperformed.
2.24
28.31
Valuation
Valuation Rating
The Price/Earnings Ratio is 6.58, which indicates a rather cheap valuation of SOLB.
SOLB's Price/Earning Ratio is a bit cheaper than the industry average which is at 10.80.
The Forward Price/Earnings Ratio of 8.30 indicates a rather cheap valuation of SOLB.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a price book ratio of 0.93, SOLB is valued rather cheaply.
Compared to an average industry price book ratio of 1.84, SOLB is valued rather cheaply
Compared to an average industry Enterprise Value to EBITDA ratio of 6.82, SOLB is valued rather cheaply
VS Industry
Price/Earnings (6.58) VS Industry: 68% outperformed.
48.09
1.72
Price/Book (0.93) VS Industry: 79% outperformed.
15.59
0.29
Enterprise Value/ EBITDA (3.97) VS Industry: 80% outperformed.
17.81
1.69
Growth
Growth Rating
SOLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.67%, which is quite impressive.
The Revenue has grown by 46.01% in the past year. This is a very strong growth!
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
Measured over the past 5 years, SOLB shows a small growth in Earnings Per Share. The EPS has been growing by 4.23% on average per year.
SOLB is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 3.62% yearly.
The EPS growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.
SOLB shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 2.62% yearly.
SOLB is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 9.05% yearly.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 4.23% | 1.15% | 79.67% | 59.77% | 10.22% | 7.62% | 3.62% |
| Revenue | 2.62% | 0.4% | 46.01% | 32.68% | 14.7% | 10.41% | 9.05% |
Health
Health Rating
When comparing the Debt to Equity Ratio of 0.23 to an average industry Debt to Equity of 0.35, SOLB is way less dependent on financing that its industry peers.
SOLB has a Current Ratio of 1.33. This is a normal value and indicates that SOLB is financially healthy and should not expect problems in meeting its short term obligations.
SOLB has a Quick Ratio comparable to the industry average, which is at 1.05.
SOLB has an Altman-Z score of 1.92. This is not the best score and indicates that SOLB is in the grey zone with still only limited risk for bankruptcy at the moment.
SOLB has a Piotroski-F score of 5.00. This indicates an average health and profitability for SOLB.
Compared to an average industry Current Ratio of 1.85, SOLB is worse placed to pay its short term obligations than its industry peers.
A Quick Ratio of 1.00 indicates that SOLB may have some problems paying its short term obligations.
Compared to an average industry Altman-Z score of 3.03, SOLB is in worse financial state than most of its industry peers. 83% of its industry peers have a better Altman-Z score.
VS Industry
Debt/Equity (0.23) VS Industry: 65% outperformed.
1.10
0.00
Quick Ratio (1) VS Industry: 41% outperformed.
0.55
8.56
Current Ratio (1.33) VS Industry: 24% outperformed.
0.72
8.56
Altman-Z (1.92) VS Industry: 17% outperformed.
-2.72
7.78
Dividend
Dividend Rating
The dividend of SOLB is growing, but earnings are growing more, so the dividend growth is sustainable.
22.51% of the earnings are spent on dividend by SOLB. This is a low number and sustainable payout ratio.
SOLB has a Yearly Dividend Yield of 2.61%.
Compared to an average industry Dividend Yield of 2.82, SOLB has a dividend in line with its industry peers.
SOLB's Dividend Yield is comparable with the S&P500 average which is at 2.55.
VS Industry
Dividend Yield (2.61%) VS Industry: 42% outperformed.
0.95
22.31
SOLVAY SA101.175
EBR:SOLB (3/21/2023, 12:55:04 PM)+3.31 (+3.39%)
| GICS Sector | Materials | ||
| GICS IndustryGroup | Materials | ||
| GICS Industry | Chemicals | ||
| Earnings (Last) | N/A N/A | Earnings (Next) | N/A N/A |
| Inst Owners | N/A | Inst Owner Change | N/A |
| Ins Owners | N/A | Ins Owner Change | N/A |
| Market Cap | 10.49B | Analysts | 71.67 |
| Price Target | 118.44 (17.06%) | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.61% |
| Dividend Growth(5Y) | 0.88% | DP | 22.51% |
| Div Incr Years | 1 | Div Non Decr Years | 3 |
| Ex-Date | N/A | ||
| EPS beat(2) | 2 | Avg EPS beat(2) | 32.96% |
| Min EPS beat(2) | 22.68% | Max EPS beat(2) | 43.24% |
| EPS beat(4) | 4 | Avg EPS beat(4) | 38.48% |
| Min EPS beat(4) | 22.68% | Max EPS beat(4) | 44.95% |
| Revenue beat(2) | 2 | Avg Revenue beat(2) | 25.65% |
| Min Revenue beat(2) | 25.46% | Max Revenue beat(2) | 25.84% |
| Revenue beat(4) | 4 | Avg Revenue beat(4) | 25.72% |
| Min Revenue beat(4) | 22.78% | Max Revenue beat(4) | 28.81% |
| PT rev (1m) | 2.81% | PT rev (3m) | 6.26% |
| EPS NQ rev (1m) | 23.84% | EPS NQ rev (3m) | 26.72% |
| EPS NY rev (1m) | 3.02% | EPS NY rev (3m) | 3.02% |
| Revenue NQ rev (1m) | 0% | Revenue NQ rev (3m) | -0.82% |
| Revenue NY rev (1m) | -2.61% | Revenue NY rev (3m) | -2.61% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.58 | ||
| Fwd PE | 8.3 | ||
| P/S | 0.68 | ||
| P/FCF | 10.51 | ||
| P/OCF | 5.91 | ||
| P/B | 0.93 | ||
| P/tB | 1.95 | ||
| EV/EBITDA | 3.97 |
| EPS(TTM) | 15.38 | EY | 15.2% |
| EPS(NY) | 12.2 | Fwd EY | 12.05% |
| FCF(TTM) | 9.63 | FCFY | 9.52% |
| OCF(TTM) | 17.13 | OCFY | 16.93% |
| SpS | 149 | BVpS | 108.68 |
| TBVpS | 51.99 | PEG (NY) | 0.11 |
| PEG (5Y) | 1.55 | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.35% | ||
| ROE | 15.78% | ||
| ROIC | 12.12% | ||
| ROICexc | 12.83% | ||
| ROICexgc | 20.2% | ||
| OM | 14.88% | ||
| PM | 11.51% | ||
| GM | 24.4% |
| ROICexgc(3y) | 12.01% | ROICexcg growth 3Y | 5.02% |
| ROICexcg growth 5Y | 7.68% | ROICexc(3y) | 7.01% |
| ROICexc growth 3Y | 9.41% | ROICexc growth 5Y | 12.02% |
| OM growth 3Y | 1.12% | OM growth 5Y | 2.97% |
| PM growth 3Y | 4.04% | PM growth 5Y | 4.31% |
| GM growth 3Y | -1.6% | GM growth 5Y | -1.92% |
| F-Score | 5 | Asset Turnover | 0.64 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.4 | ||
| Debt/EBITDA | 1.07 | ||
| Cap/Depr | 89% | ||
| Profit Quality | 56.16% | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.92 |
| F-Score | 5 | WACC | 7.92% |
| ROIC/WACC | 2.55 | Cap/Depr(3y) | 47.34% |
| Cap/Depr(5y) | 60.32% | Profit Quality(3y) | N/A |
| Profit Quality(5y) | N/A | ||
| EPS 1Y | 79.67% | EPS 3Y | 1.15% |
| EPS 5Y | 4.23% | EPS growth Q2Q | 85.55% |
| EPS Next Y | 59.77% | EPS Next 2Y | 10.22% |
| EPS Next 3Y | 7.62% | EPS Next 5Y | 3.62% |
| Revenue growth 1Y | 46.01% | Revenue growth 3Y | 0.4% |
| Revenue growth 5Y | 2.62% | Revenue growth Q2Q | 53.98% |
| Revenue Next Year | 32.68% | Revenue Next 2Y | 14.7% |
| Revenue Next 3Y | 10.41% | Revenue Next 5Y | 9.05% |
| EBIT growth 1Y | 92.46% | EBIT growth 3Y | 1.52% |
| EBIT growth 5Y | 5.67% | EBIT Next Year | 120.92% |
| EBIT Next 3Y | 23.37% | EBIT Next 5Y | 11.15% |
| FCF growth 1Y | 29.61% | FCF growth 3Y | -0.91% |
| FCF growth 5Y | 1.35% | OCF growth 1Y | 26.15% |
| OCF growth 3Y | -4.48% | OCF growth 5Y | -3.46% |
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the EuroNext
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the EuroNext
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the EuroNext
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the EuroNext